PMID: 8613484Nov 1, 1995Paper

Animal models for complement deficiencies

Journal of Clinical Immunology
M M Frank

Abstract

The complement system plays a key role in host defense and in the development of autoimmunity. Three types of animal models of complement-mediated disease have traditionally been used: they involve normal animals, animals with spontaneously arising genetic deficiency, and animals treated with complement-inactivating agents. All of these approaches have had partial success in our attempts to understand complement mechanisms. Most animal models of genetic deficiency have been studied relatively little, as the availability of such animals is limited. C4, C2, and partial C3 deficiency in the guinea pig are well characterized, although only C4 deficiency in the guinea pig has been exclusively studied. C3 deficiency in the dog and C6 deficiency in the rabbit are well described, although studies are limited in number. C6 deficiency in the rat has been described recently and C5 deficiency in inbred mice strains has been studied fairly extensively. Factor H deficiency in the Yorkshire pig has also been described. Relatively few agents that inhibit complement are in use. Most widely used in animal studies is cobra venom factor. This inactivates the alternative complement pathway in the fluid phase and thereby depletes complement protein ...Continue Reading

References

Jan 1, 1992·Clinical Immunology and Immunopathology·M M FrankL F Fries
Sep 1, 1991·Immunology Today·M M Frank, L F Fries
Dec 1, 1990·Immunology Today·J L PlattF H Bach
Sep 1, 1986·The Journal of Clinical Investigation·E C BöttgerD Bitter-Suermann
Feb 1, 1985·The Journal of Clinical Investigation·K B YanceyT J Lawley
Jun 1, 1969·The Journal of Experimental Medicine·R B JohnstonF S Rosen
Dec 1, 1969·The Journal of Experimental Medicine·H S ShinW B Wood
Jan 1, 1982·International Archives of Allergy and Applied Immunology·Y Hitomi, S Fujii
Jan 1, 1984·Springer Seminars in Immunopathology·T E Hugli
Jan 1, 1984·Annual Review of Immunology·K A JoinerM M Frank
Jan 1, 1994·Springer Seminars in Immunopathology·M C Moffitt, M M Frank
Jan 1, 1994·Springer Seminars in Immunopathology·Z Fishelson
Jan 1, 1994·Springer Seminars in Immunopathology·B P Morgan, S Meri
Jan 1, 1994·Springer Seminars in Immunopathology·K R KalliD T Fearon
Jun 1, 1993·Clinical Immunology and Immunopathology·H D OchsR J Wedgwood
Feb 16, 1963·Nature·S DUBISKI, B CINADER
Nov 23, 1963·Nature·B CINADER, S DUBISKI

❮ Previous
Next ❯

Citations

Feb 5, 1999·Clinical and Experimental Immunology·E SakinieneA Tarkowski
May 16, 2000·Immunology·C H NielsenR G Leslie
Apr 5, 1997·Annals of the New York Academy of Sciences·M J WalportM Botto
Feb 14, 1998·Kidney International·R J QuiggM C Carroll
Jan 27, 2012·The Veterinary Journal·M N M HezmeeP C Mills
Feb 19, 1998·Scandinavian Journal of Immunology·M PeknaM Pekny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.